Upperton Recognised in Sunday Times 100 Fastest-Growing Companies 2024
We’re honoured to announce that Upperton has been recognised as one of the Sunday Times’ 100 fastest-growing companies in the UK for 2024.
Scientist Spotlight: A Journey of Innovation with Shailesh Mistry
Discover more about our team. In this Scientist Spotlight:, meet our Development Manager, Shailesh Mistry on his journey with Upperton.
Dry Powder Formulation: The Next Generation
Outlining the Trends and Challenges in the Inhaled Drug Delivery Market, with a Special Focus on Dry Powder Formulation.
Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.
Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.
Upperton Strengthens Capabilities with Installation of Gerteis Roller Compactor
Upperton strengthens capabilities with installation of Gerteis roller compactor at Nottingham gmp manufacturing facility.
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
Continued Growth During 2023 – Milestones and Achievements
What a year 2023 has been. A year of remarkable growth and achievements, award-winning, and new standards in gmp manufacturing facilities.
Upperton Pharma Solutions Win’s Prestigious King’s Award for Enterprise: International Trade 2023
Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development and manufacture of innovative drug formulations, has been announced as a winner of the King’s Award for Enterprise, International Trade. The King’s Award for Enterprise is a highly prestigious award for UK businesses who have demonstrated outstanding innovation in their industry. […]
Nasal Inhalation Delivery – An Introduction Guide
An introduction to nasal delivery The delivery of APIs via nasal inhalation is of growing interest to companies looking to exploit the benefits of this delivery route. Delivery targets are typically broken down into three categories Local delivery to the nasal membranes (e.g. for vaccines, antivirals, prophylactics) Systemic delivery by absorption into the bloodstream (e.g. […]
Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ
20th April 2023 : Press Release Nottingham, UK, 20th April: Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK. Part of Upperton’s £15m investment program announced in January this year, the state-of-the-art facility has benefited from a […]